SCHEMBL18633015

SCHEMBL18633015

CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(CI)c3)ncnc2cc1OCC1CC2(CCN(C)CC2)C1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 20/20 0.67
▸ ERBB2 P04626 12/20 0.59
▸ CIT O14578 1/20 0.54
▸ GAK O14976 1/20 0.54
▸ EPHB6 O15197 1/20 0.54
▸ RIPK2 O43353 1/20 0.54
▸ STK10 O94804 1/20 0.54
▸ ABL1 P00519 1/20 0.54
▸ LCK P06239 1/20 0.54
▸ LYN P07948 1/20 0.54
▸ RET P07949 1/20 0.54
▸ CHRM2 P08172 1/20 0.54
▸ MET P08581 1/20 0.54
▸ HCK P08631 1/20 0.54
▸ SRC P12931 1/20 0.54
▸ PHKG2 P15735 1/20 0.54
▸ ADRA2B P18089 1/20 0.54
▸ ERBB3 P21860 1/20 0.54
▸ AXL P30530 1/20 0.54
▸ CCKAR P32238 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18633014 0.93 EGFR (0.69) EGFRERBB2GAKRIPK2LCK
SCHEMBL18633148 0.92 EGFR (0.71) EGFRERBB2GAKRIPK2LCK
SCHEMBL15090487 0.91 EGFR (0.81) EGFRERBB2CITGAKEPHB6
SCHEMBL255942 0.91 EGFR (0.81) EGFRERBB2CITGAKEPHB6
SCHEMBL256544 0.84 EGFR (0.74) EGFRERBB2CITGAKEPHB6
SCHEMBL15090569 0.84 EGFR (0.84) EGFRERBB2GAKRIPK2LCK
SCHEMBL15090527 0.84 EGFR (0.84) EGFRERBB2GAKRIPK2LCK
Hydrochloric Acid SCHEMBL15104756 0.84 EGFR (0.83) EGFRERBB2GAKRIPK2LCK
Hydrochloric Acid SCHEMBL15090765 0.84 EGFR (0.83) EGFRERBB2GAKRIPK2LCK
SCHEMBL15090676 0.84 EGFR (0.83) EGFRERBB2GAKRIPK2LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2612860-B1 QUINAZOLINE DERIVATIVES SUBSTITUTED BY ANILINE, PREPARATION METHOD AND USE THEREOF XUANZHU PHARMA CO LTD (CN) 2017-03-15 — — EP disclosed
Send feedback